Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Interview: Medtech’s Unique Market-Access Routes Demand Tailored Response For EU-Wide HTA

Executive Summary

The European Commission is looking at initiatives for employing health technology assessment at the EU level. But the medtech industry is concerned that its own specific market-access routes are being overlooked while the commission focuses too narrowly on solutions more suited to the pharma industry. MedTech Europe’s Yves Verboven explains the industry's case in an interview.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT103987

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel